Gustave Roussy
Gustave Roussy
Villejuif, Val de Marne, France17 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis | Not yet recruiting | Phase 1 | 2026-09-02 | NCT07544225 | |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, brainstem cancer, central nervous system cancer, central nervous system disorder, diffuse intrinsic pontine glioma, diffuse midline glioma, H3 K27M-mutant, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 3 | 2026-08-13 | NCT05476939 | |
| European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors | childhood malignant neoplasm, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-07-10 | NCT02813135 | |
| Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 2 | 2026-04-21 | NCT07303387 | |
| Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Phase 2 | 2026-04-02 | NCT03703050 | |
| Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults | childhood malignant neoplasm, neoplasm | Recruiting | Not stated | 2026-03-31 | NCT04477681 | |
| Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 3 | 2026-03-30 | NCT03519048 | |
| Prognostic and Predictive Biomarkers in Ovarian Cancers | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Not applicable | 2026-03-20 | NCT03010124 | |
| ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, thyroid gland disorder, thyroid tumor | Active, not recruiting | Phase 3 | 2026-03-06 | NCT03570021 | |
| Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults | Stomatognathic Diseases, mouth disorder, stomatitis | Recruiting | Phase 3 | 2026-02-06 | NCT03983369 | |
| Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma | Head and Neck Mucosal Melanomas | Active, not recruiting | Phase 2 | 2026-01-20 | NCT03313206 | |
| Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs | cancer, neoplasm | Active, not recruiting | Not applicable | 2025-06-26 | NCT03984318 | |
| Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2025-05-08 | NCT03406247 | |
| Neurocognitive Risks in Children With Solid Tumors | Solid Tumor in Children | Recruiting | Not stated | 2024-12-13 | NCT03609112 | |
| Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation | childhood malignant neoplasm, neoplasm | Recruiting | Not applicable | 2024-05-29 | NCT03604627 | |
| Two Chemotherapy Regimens Plus or Minus Bevacizumab | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 2 | 2024-05-08 | NCT03351296 | |
| Preoperative Radiotherapy And ASTX660 in Rectum Cancer | Locally-advanced Rectal Cancer | Recruiting | Phase 1 | 2024-02-08 | NCT05912075 |